
    
      PROTOCOL OUTLINE:

      This is a dose escalation study.

      Patients receive vasoactive intestinal peptide (VIP) IV over either 6 or 12 hours.

      Cohorts of 3 patients each receive escalating doses of VIP over either 6 or 12 hours until
      the maximum tolerated dose is determined.

      Patients are followed for 30 days.
    
  